Private company

ARCH Venture Fund X, L.P.

American company, incorporated in Delaware. Summary from the record

Last updated Oct 21, 2026.

Overview

HeadquartersDE¹

See how the biggest companies compare on our leaderboards

Corporate structure

ARCH Venture Fund X, L.P. sits at the top of its group. 6 entities, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.

ARCH Venture Fund X, L.P. DE
- EQRx, Inc. Stake · Cambridge, Massachusetts
- Erasca, Inc. Stake · San Diego, California
- Maze Therapeutics, Inc. Stake · South San Francisco, California
- Prime Medicine, Inc. Stake · Cambridge, Massachusetts
- Verve Therapeutics, Inc. Stake · Boston, Massachusetts

Built from major holders from Schedules 13D and 13G; stakes of 5% or more it reported on Schedules 13D and 13G (5 companies). Each entity in the chart links to its source.

Stakes it holds

ARCH Venture Fund X, L.P. has told the SEC it owns more than 5% of 5 companies, latest first (Schedules 13D and 13G).

Maze Therapeutics, Inc.SCHEDULE 13G May 15, 2025²
Erasca, Inc.SC 13G/A Feb 10, 2022 to Nov 14, 2024³
EQRx, Inc.SC 13G/A Feb 11, 2022 to Nov 17, 2023⁴
Prime Medicine, Inc.SC 13G Feb 13, 2023⁵
Verve Therapeutics, Inc.SC 13G/A Feb 9, 2022 to Feb 13, 2023⁶

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARARCH Venture Fund X, L.P. filings on SEC EDGAR
2
SEC EDGARARCH Venture Fund X, L.P. SCHEDULE 13G on Maze Therapeutics, Inc.
3
SEC EDGARARCH Venture Fund X, L.P. SC 13G/A on Erasca, Inc.
4
SEC EDGARARCH Venture Fund X, L.P. SC 13G/A on EQRx, Inc.
5
SEC EDGARARCH Venture Fund X, L.P. SC 13G on Prime Medicine, Inc.
6
SEC EDGARARCH Venture Fund X, L.P. SC 13G/A on Verve Therapeutics, Inc.